Related Experiment Video
Updated: Mar 26, 2026
10:08
Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
14.1K
Heart acceleration and deceleration capacities associated with dilated cardiomyopathy
Cao Zou1, Hongkai Dong1, Fengyan Wang1
1Cardiology Department, First Affiliated Hospital of Soochow University, Suzhou, China.
European Journal of Clinical Investigation
|January 24, 2016
Summary
Heart rate acceleration capacity and deceleration capacity are independent risk factors for dilated cardiomyopathy (DCM). Acceleration capacity also predicts heart failure worsening in DCM patients.
Area of Science:
- Cardiology
- Autonomic Nervous System Research
- Cardiac Electrophysiology
Background:
- Heart rate deceleration capacity and acceleration capacity are emerging indicators of cardiac neural regulation.
- Dilated cardiomyopathy (DCM) affects cardiac electrophysiology, but its relationship with these autonomic indices is not well understood.
Purpose of the Study:
- To investigate the association between heart rate acceleration capacity, deceleration capacity, and DCM.
- To determine if these autonomic markers are independent risk factors for DCM.
Main Methods:
- A study involving 66 DCM patients and 209 controls.
- Collection of demographic, echocardiographic, and heart rate variability data, including deceleration capacity and acceleration capacity.
- Analysis using multiple logistic regression to assess the association patterns.
Main Results:
- Deceleration capacity (OR 7.97) and acceleration capacity (OR 0.09) were identified as independent risk factors for DCM.
- Acceleration capacity, fastest heart rate, and left ventricular ejection fraction (LVEF) were associated with heart failure grade.
- Acceleration capacity (OR 1.32) and LVEF (OR 0.46) remained independent predictors of heart failure severity.
Conclusions:
- Heart rate acceleration capacity and deceleration capacity are significant independent risk factors for DCM.
- Acceleration capacity serves as a predictive marker for heart failure exacerbation in individuals with DCM.
Keywords:
Dilated cardiomyopathyelectrophysiologyheart rate acceleration capacityheart rate deceleration capacityMore Related Videos
07:49Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
2.1K
08:19Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs
Published on: July 12, 2022
3.7K
Related Concept Videos
01:30Cardiomyopathy II: Dilated Cardiomyopathy
744
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
744
01:26Imbalances in Cardiac Output
3.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.4K
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
687
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
687
01:29Cardiomyopathy V: Interprofessional Care
621
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
621
01:29Pathophysiology of Cardiac Performance
1.9K
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.9K
01:29Heart Failure II: Pathophysiology
1.3K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K